ENDRA Life Sciences
NDRA
16 hedge funds and large institutions have $80.6K invested in ENDRA Life Sciences in 2024 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more funds holding
Funds holding: 8 → 16 (+8)
3.12% less ownership
Funds ownership: 3.12% → 0% (-3.1%)
47% less capital invested
Capital invested by funds: $153K → $80.6K (-$72.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$80.9K |
| 2 |
Jane Street
New York
|
+$19.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$27.8K |
| 2 |
VF
Virtu Financial
New York
|
-$20K |
| 3 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$431 |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$191 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$38 |
NDRA Hedge Fund Activity: Q2 2024 in Review
16 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q2 2024, worth a combined $80.6K — down 47% from $153K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new NDRA positions and 2 closed out — a net gain of 8 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $80.9K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $27.8K sold.
- 16 institutional investors held ENDRA Life Sciences (NDRA) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $80.6K of ENDRA Life Sciences stock for Q2 2024, down 47% quarter-over-quarter.
- 10 funds opened new ENDRA Life Sciences positions in Q2 2024 and 2 closed out, a net change of +8 holders.
- The largest ENDRA Life Sciences buyer in Q2 2024 was HRT Financial, an estimated $80.9K added.
- The largest ENDRA Life Sciences seller in Q2 2024 was Two Sigma Securities, an estimated $27.8K sold.
Based on aggregated 13F filings for Q2 2024.